EverSource Wealth Advisors’s ProKidney PROK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$136 Buy
+82
New +$138 ﹤0.01% 4365
2025
Q4
– Sell
-38
Closed -$92 – 4402
2025
Q3
$92 Sell
38
-979
-96% -$2.61K ﹤0.01% 4208
2025
Q2
$602 Buy
1,017
+750
+281% +$584 ﹤0.01% 3856
2025
Q1
$234 Buy
267
+230
+622% +$319 ﹤0.01% 3673
2024
Q4
$63 Buy
+37
New +$67 ﹤0.01% 3613

Other funds holding PROK

EverSource Wealth Advisors's PROK Position: Q3 2026 in Review

EverSource Wealth Advisors opened a new position in ProKidney (PROK) in Q3 2026: 82 shares worth $136. The stake represents ﹤0.01% of the portfolio and ranks #4365 among its holdings. This is a return to the name: EverSource Wealth Advisors previously reported a position in PROK as recently as Q3 2025.

EverSource Wealth Advisors first reported a position in PROK in Q4 2024 and has held it in 5 quarters since. The position peaked at $602 in Q2 2025. 67 funds tracked by Wall St. Rank hold PROK as of Q3 2026.

  • EverSource Wealth Advisors held 82 shares of ProKidney worth $136 as of Q3 2026.
  • ProKidney was a new EverSource Wealth Advisors position in Q3 2026.
  • ProKidney made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q3 2026, its #4365 holding.
  • EverSource Wealth Advisors first reported a position in ProKidney in Q4 2024 and has held it in 5 quarters since.
  • EverSource Wealth Advisors's ProKidney position peaked at $602 in Q2 2025.
  • 67 funds tracked by Wall St. Rank held ProKidney as of Q3 2026.

Based on EverSource Wealth Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.